Approxima

Approxima sits in a sweet spot: it's not another AI QA agent that generates tests from scratch, but a smarter layer that keeps your existing Playwright suite healthy. The killer feature is auto-healing selectors—when your UI changes, Approxima suggests updates instead of failing your build. This directly tackles the 'test maintenance tax' that grows as your app evolves. Writing tests in plain English is a nice bonus—it lowers the barrier for QA engineers who are comfortable with Playwright but not with writing complex selector chains. The platform handles the technical details, letting you describe the user flow naturally. Deterministic execution is another plus. Flaky tests often stem from timing issues or race conditions; Approxima aims to make runs reliable, so a failure means a real bug, not a random timeout. That's a huge trust builder for CI. However, Approxima is in beta. Public documentation is thin, and the credit-based model is a bit opaque—you'll need to monitor usage as your suite grows. It also requires you to already be on Playwright, so teams using other frameworks won't benefit. There's no lock-in: if you stop using Approxima, your tests remain as Playwright tests. That's a refreshing stance in a market where many tools force you into their ecosystem. For whom: QA engineers and developers who dread flaky test failures and want to reclaim time. For whom not: teams wanting full no-code AI testing or those with strict compliance requiring manual test review. If you're happy maintaining simple, stable tests, Approxima might be overkill. Overall, Approxima is a focused tool that solves a real pain point with minimal friction. Keep an eye on its roadmap and pricing after beta—the free tier is generous now, but usage costs could rise.